In episode #9 of the ChalkTalk podcast, we speak with Alexandra Lansky, MD, FACC, FAHA, FSCAI, FESC, Professor of Medicine in Cardiology, and Director of Yale Cardiovascular Clinical Research Program at Yale University School of Medicine in New Haven, Connecticut, about her recent gender analyses at TCT21 and SCAI22, in which she presented the respective 30-day and 1-year outcomes broken out by women vs men that were enrolled in the Disrupt CAD clinical program.
Dr. Lansky shares the genesis of the analysis - previous research showing that female atherectomy patients have an increased risk for angiographic complications than their male counterparts,[i] and sheds light on what makes coronary IVL unique from a safety perspective. She concludes by discussing the recent publication of SCAI’s “Expert Consensus Statement on Sex-Specific Consideration in Myocardial Revascularization” in JSCAI, which referenced the role of IVL in female patients. The SCAI guidelines concluded, “while additional evidence is needed, these results taken in the context of outcomes with atherectomy devices suggest that IVL may emerge as a first-line therapy for plaque modification of calcified lesions in women specifically.”
We hope you enjoy the episode and for more information on coronary IVL in women, please visit TimeForAnIntervention.com.
Read More
Topics:
Shockwave Behind-the-Scenes,
Coronary IVL,
Shockwave Breaking News,
IVL Technology,
Coronary Cases,
Coronary Clinical Data,
Shockwave C2,
Coronary Conferences,
Coronary IVL - U.S.,
ChalkTalk Podcast
In a few weeks, we are headed to a city known for its sunshine and southern hospitality, Atlanta, Georgia, where SCAI 2022 is taking place this year. At the conference, leading calcium experts will share the 1-year results from the Randomized Disrupt PAD III Trial and 1-year sex specific outcomes with Coronary IVL.
Read More
Topics:
Coronary IVL,
IVL Case,
Peripheral IVL,
Shockwave Breaking News,
IVL Technology,
DISRUPT PAD,
Coronary Cases,
Peripheral Cases,
PAD Applications - BTK,
Peripheral Conferences,
SWAV News,
Shockwave C2,
Coronary Conferences,
Shockwave M5,
Shockwave S4,
PAD Applications - TEVAR,
Coronary IVL - U.S.,
ShockwaveM5+
If you missed the two Shockwave IVL sessions at EuroPCR 2021, or would like to watch the symposia again, you’re in luck. The Shockwave IVL content from EuroPCR 2021 is available here.
Read More
Topics:
Medical Meetings,
Coronary Cases,
Coronary Clinical Data,
Shockwave C2,
Coronary Conferences
We had the privilege of connecting with Dr. Robert Riley Director, Complex Coronary Therapeutics Program, The Christ Hospital Health System. Dr. Riley is the leading author of the abstract for the Patient-Level Pooled Analysis of the Disrupt CAD I, II, III and IV studies and presented at ACC.21 Virtual.
Read More
Topics:
Coronary IVL,
DISRUPT CAD,
Coronary Cases,
Coronary Clinical Data,
Shockwave C2,
Coronary Conferences
You know the expression – “the more things change, the more they stay the same.” Well if there’s anything that we learned over the last year, it’s that this phrase absolutely does not apply to anything related to IVL.
Read More
Topics:
Medical Meetings,
Coronary Cases,
Coronary Clinical Data,
Shockwave C2,
Coronary Conferences
Following its presentation as a late-breaking clinical at TCT Connect and simultaneous publication in the Journal of the American College of Cardiology (JACC) we sat down with Dr. Jonathan Hill, Consultant Cardiologist at the Royal Brompton Hospital in London, to get his perspective on the results, how they build on CAD I & II outcomes, and where they fit into clinician’s daily decision-making process when treating calcified lesions. We hope you enjoy his perspective.
Read More
Topics:
Coronary IVL,
DISRUPT CAD,
Coronary Clinical Data,
Shockwave C2,
Coronary Conferences
If Shockwave IVL had a personality, we’d like to think that we’d be a bit on the eccentric side. A little unconventional and taking a slightly different path than everyone else. After all, you won’t be successful in introducing a new disruptive technology if you’re marching to the same drumbeat as everyone else.
Read More
Topics:
DISRUPT CAD,
Coronary Cases,
Shockwave C2,
Coronary Conferences,
CAD Applications - Eccentric Lesions
In case you weren’t able to make it to EuroPCR’s e-Course last week, you missed a great discussion among some of coronary IVL’s most knowledgeable operators about how they’re using the technology in the real-world setting. Lucky for you, we’ve included the sponsored roundtable discussion below featuring Drs. Benjamin Honton (FR), Javier Escaned (ES) and Michael Lee (HK). We hope you enjoy hearing their perspectives from across Europe and Asia.
Read More
Topics:
Coronary IVL,
Coronary Cases,
Coronary Clinical Data,
Shockwave C2,
Coronary Conferences,
CAD Applications - Eccentric Lesions
Regardless of what party you align with or what type of calcium is the most challenging to you, CRT has a lithotripsy presentation for everyone this year in DC. Whether it’s calcified iliacs that prevent transfemoral access for TAVR and Impella procedures or calcified tibials in critical limb ischemia. Or if you’re in the EU (and the UK) and calcified bifurcations, ostials and left mains are more your cup of tea, we've got that too. Regardless of where challenging calcium presents itself, CRT will be showcasing how lithotripsy addresses it.
Read More
Topics:
Coronary Conferences
The inaugural TopShock Symposium celebrating the one-year anniversary of coronary IVL at EuroPCR 2019 was a momentous occasion for everyone who participated, but none more so than for Dr. Alfonso Jurado-Román, the winner of the case competition.
Read More
Topics:
Coronary Cases,
Shockwave C2,
Coronary Conferences